Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers | Zendy

Marian A. Spath | Zendy; Thijs Feuth | Zendy; Emily G. Allen | Zendy; Anne Smits | Zendy; Helger G. Yntema | Zendy; Andrew G. Van Kessel | Zendy; D.D.M. Braat | Zendy; Stephanie L. Sherman | Zendy; Chris M.G. Thomas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers

Author(s) -

Marian A. Spath,

Thijs Feuth,

Emily G. Allen,

Anne Smits,

Helger G. Yntema,

Andrew G. Van Kessel,

D.D.M. Braat,

Stephanie L. Sherman,

Chris M.G. Thomas

Publication year - 2011

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/der146

Subject(s) - fmr1 , anti müllerian hormone , ovarian reserve , medicine , premature ovarian failure , hormone , correlation , endocrinology , fragile x , biology , genetics , infertility , gene , mathematics , pregnancy , geometry

Carriers of a premutation (CGG repeat length 55-200) in the fragile X mental retardation (FMR1) gene are at risk for primary ovarian insufficiency (FXPOI). The anti-Müllerian hormone (AMH) level acts as a useful marker of ovarian follicle reserve and, thus, may serve to predict when this ovarian reserve becomes too low to sustain ovarian function. We investigated the intra-individual variation of AMH levels over time for premutation carriers compared with non-carriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research